Tomer Adar

Microbiota in health and diseases

Non-alcoholic fatty liver disease – A global public health perspective

Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin

Autoimmune hepatitis: a review

The Intestinal Immune System in Obesity and Insulin Resistance

Hepatocellular carcinoma

Pharmacotherapy for NASH: Current and emerging

Interaction between microbiota and immunity in health and disease

Inducing and Administering Tregs to Treat Human Disease

Mechanisms of NAFLD development and therapeutic strategies

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis

Adaptive immunity: an emerging player in the progression of NAFLD

Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Gas-phase broadband spectroscopy using active sources: progress, status, and applications [Invited]

Ulcerative colitis

Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?

New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer

Gut microbiota in human metabolic health and disease

The role of the microbiome in NAFLD and NASH

Fecal biomarkers in inflammatory bowel disease: how, when and why?

Multi-watt, multi-octave, mid-infrared femtosecond source

Directly diode-pumped, Kerr-lens mode-locked, few-cycle Cr:ZnSe\n oscillator

Frailty in inflammatory bowel diseases: an emerging concept

Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation

Liver inflammation and fibrosis

Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand

Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH

Point-of-care continuous¹³C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

Adalimumab-induced Autoimmune Hepatitis

Non-ST Elevation Myocardial Infraction after High Dose Intravenous Immunoglobulin Infusion

Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells

A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy

Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study